Delphinus backs NorFalk financing round, taking funding past EUR 5 million

PUBT · 2d ago
Delphinus backs NorFalk financing round, taking funding past EUR 5 million
  • NorFalk raised a private investment round backed by Delphinus Venture Capital to commercialize bio-based chemical ingredients.
  • Danish industrial biotech group uses enzymatic biocatalysis to convert vegetable oil and sugar into surfactants and related ingredients.
  • Funding took total capital raised since incorporation in 2022 to more than EUR 5 million.
  • Proceeds earmarked for commercialization, product refinement, scaled pilot production, platform expansion with customers or industrial partners.
  • NorFalk reported signed LOIs, more than 100 industry samples, one commercial agreement, tech transfer to a contract manufacturer.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Delphinus Venture Capital K/S published the original content used to generate this news brief on August 24, 2026, and is solely responsible for the information contained therein.